(Q40700950)

22 September 2017

1 reference

title

Radioiodinated metaiodobenzylguanidine: a review of its biodistribution and pharmacokinetics, drug interactions, cytotoxicity and dosimetry (English)

1 reference

22 September 2017

0 references

1 reference

A R Wafelman

1

1 reference

22 September 2017

C A Hoefnagel

series ordinal

2

1 reference

22 September 2017

R A Maes

series ordinal

3

1 reference

22 September 2017

J H Beijnen

series ordinal

4

1 reference

22 September 2017

1 June 1994

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

22 September 2017

1 reference

22 September 2017

21

1 reference

22 September 2017

6

1 reference

22 September 2017

545-559

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00173043

22 September 2017

0 references

cites work

131I-meta-iodobenzylguanidine scintigraphy of neuroblastomas.

1 reference

12 December 2020

131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizes

1 reference

12 December 2020

Comparison of the sodium dependency of uptake of meta-lodobenzylguanidine and norepinephrine into cultured bovine adrenomedullary cells.

1 reference

12 December 2020

Radionuclide therapy of neural crest tumors

1 reference

12 December 2020

Modification by nifedipine of 131I-meta-iodobenzylguanidine kinetics in malignant phaeochromocytoma.

1 reference

12 December 2020

Salivary gland accumulation of meta-[131I]iodobenzylguanidine

1 reference

12 December 2020

Cytotoxic and antitumor effects of the norepinephrine analogue meta-iodo-benzylguanidine (MIBG)

1 reference

12 December 2020

Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours.

1 reference

12 December 2020

Stability and pharmacokinetics of m-[131I]iodobenzylguanidine in patients

1 reference

12 December 2020

Uptake and storage of m-iodobenzylguanidine are frequent neuronal functions of human neuroblastoma cell lines

1 reference

12 December 2020

Radionuclide therapy of cancer: particle range and therapeutic effectiveness

1 reference

12 December 2020

Portrayal of pheochromocytoma and normal human adrenal medulla by m-[123I]iodobenzylguanidine: concise communication

1 reference

12 December 2020

Rapid clearance of iodine-131 MIBG from the heart and liver of patients with adrenergic dysfunction and pheochromocytoma

1 reference

12 December 2020

Labetalol reduces iodine-131 MIBG uptake by pheochromocytoma and normal tissues

1 reference

12 December 2020

Nuclear medicine in the monitoring of organ function and the detection of injury related to cancer therapy

1 reference

12 December 2020

Iodine-123-4-amino-3-iodobenzylguanidine, a new sympathoadrenal imaging agent: comparison with iodine-123 metaiodobenzylguanidine

1 reference

12 December 2020

Inverse relationship between cardiac accumulation of meta-[131I]iodobenzylguanidine (I-131 MIBG) and circulating catecholamines in suspected pheochromocytoma

1 reference

12 December 2020

gamma-Interferon increases metaiodobenzylguanidine incorporation and retention in human neuroblastoma cells

1 reference

12 December 2020

Quantitative study of radioiodinated metaiodobenzylguanidine uptake in children with neuroblastoma: correlation with tumor histopathology

1 reference

12 December 2020

VMA-negative, MIBG scan-positive neuroblastoma in children

1 reference

12 December 2020

In vitro therapeutic targeting of neuroblastomas using 125I-labelled meta-iodobenzylguanidine

1 reference

12 December 2020

Myocardial uptake of meta-[123I]-iodobenzylguanidine [( 123I]-MIBG) in patients with myocardial infarct

1 reference

12 December 2020

Metabolism of iodine-131 metaiodobenzylguanidine in patients with metastatic pheochromocytoma

1 reference

12 December 2020

Efficacy and safety of [131I]metaiodobenzylguanidine therapy for patients with refractory neuroblastoma

1 reference

12 December 2020

Pharmacokinetics and intracellular distribution of the tumor-targeted radiopharmaceutical m-iodo-benzylguanidine in SK-N-SH neuroblastoma and PC-12 pheochromocytoma cells

1 reference

12 December 2020

Dosimetry of iodine 131 metaiodobenzylguanidine for treatment of resistant neuroblastoma: results of a UK study

1 reference

12 December 2020

Calculating radiation absorbed dose for pheochromocytoma tumors in 131-I MIBG therapy.

1 reference

12 December 2020

Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man

1 reference

12 December 2020

Pre- and post-treatment distribution pattern of 123I-MIBG in patients with phaeochromocytomas and paragangliomas

1 reference

12 December 2020

A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG)

1 reference

12 December 2020

Imaging of phaeochromocytoma and adrenal medulla with 123I-meta-iodobenzyl guanidine

1 reference

12 December 2020

Uterine uptake of iodine-123 metaiodobenzylguanidine during the menstrual phase of uterine cycle

1 reference

12 December 2020

Dosimetric aspects of radiolabeled antibodies for tumor therapy

1 reference

12 December 2020

Uptake of iodine-123 MIBG by pheochromocytomas, paragangliomas, and neuroblastomas: a histopathological comparison

1 reference

12 December 2020

Meta-iodobenzylguanidine (mIBG) uptake and storage in the human neuroblastoma cell line SK-N-BE(2C).

1 reference

12 December 2020

Glomerular filtration rate and the kinetics of 123I-metaiodobenzylguanidine

1 reference

12 December 2020

Pregnancy after high therapeutic doses of iodine-131 in differentiated thyroid cancer: potential risks and recommendations

1 reference

12 December 2020

Role of [131I]metaiodobenzylguanidine therapy in carcinoids

1 reference

12 December 2020

Determination of m-iodobenzylguanidine in serum and urine by high-performance liquid chromatography

1 reference

12 December 2020

Accumulation of m-iodobenzylguanidine by neuroblastoma cells results from independent uptake and storage mechanisms.

1 reference

12 December 2020

The use of [131I]metaiodobenzylguanidine in the treatment of neuroblastoma after conventional therapy

1 reference

12 December 2020

Cerebral uptake of MIBG: adrenoceptors visualized?

1 reference

12 December 2020

Extragranular storage of the neuron blocking agent meta-iodobenzylguanidine (MIBG) in human neuroblastoma cells

1 reference

12 December 2020

Cytotoxic effects of m-[131I]- and m-[125I]iodobenzylguanidine on the human neuroblastoma cell lines SK-N-SH and SK-N-LO

1 reference

12 December 2020

Specific uptake of m-[125I]iodobenzylguanidine in the human neuroblastoma cell line SK-N-SH.

1 reference

12 December 2020

Myocardial imaging in man with I-123 meta-iodobenzylguanidine

1 reference

12 December 2020

Uptake of meta-iodobenzylguanidine by bovine chromaffin granule membranes

1 reference

12 December 2020

Uptake of the neuron-blocking agent meta-iodobenzylguanidine and serotonin by human platelets and neuro-adrenergic tumour cells

1 reference

12 December 2020

The biodistribution and pharmacokinetics of meta-iodobenzylguanidine in childhood neuroblastoma

1 reference

12 December 2020

Intracellular localization of metaiodobenzyl guanidine in human neuroblastoma cells by electron spectroscopic imaging

1 reference

12 December 2020

[131I]-metaiodobenzylguanidine in the treatment of metastatic neuroblastoma. Clinical, pharmacological and dosimetric aspects

1 reference

12 December 2020

High-performance liquid chromatographic determination of m-iodobenzylguanidine in urine of cancer patients

1 reference

12 December 2020

The uptake and retention of metaiodobenzyl guanidine by the neuroblastoma cell line NB1-G.

1 reference

12 December 2020

The treatment of resistant neuroblastoma with 131I-mIBG: alternative methods of dose prescription

1 reference

12 December 2020

Platelet uptake of the pheochromocytoma-scanning agent 131I-meta-iodobenzylguanadine

1 reference

12 December 2020

Implications of the uptake of 131I-radiolabelled meta-iodobenzylguanidine (mIBG) for the targeted radiotherapy of neuroblastoma

1 reference

12 December 2020

MIBG scintigraphy of a patient with pheochromocytoma on labetalol therapy

1 reference

12 December 2020

Treatment of neuroblastoma with [125I]metaiodobenzylguanidine

1 reference

12 December 2020

Active uptake and extravesicular storage of m-iodobenzylguanidine in human neuroblastoma SK-N-SH cells

1 reference

12 December 2020

Myocardial uptake of metaiodobenzylguanidine in patients with left ventricular hypertrophy secondary to valvular aortic stenosis

1 reference

12 December 2020

Effect of uptake-one inhibitors on the uptake of norepinephrine and metaiodobenzylguanidine.

1 reference

12 December 2020

The radiotoxicity of iodine-125 in mammalian cells II. A comparative study on cell survival and cytogenetic responses to 125IUdR, 131TUdR, and 3HTdR

1 reference

12 December 2020

Comparison of MIBG and monoamines uptake mechanisms: Pharmacological animal and blood platelets studies

1 reference

12 December 2020

Evaluation of metaiodobenzylguanidine uptake by the norepinephrine, dopamine and serotonin transporters

1 reference

12 December 2020

The curability of tumours of differing size by targeted radiotherapy using 131I or 90Y

1 reference

12 December 2020

Radionuclide diagnosis and therapy of neural crest tumors using iodine-131 metaiodobenzylguanidine

1 reference

12 December 2020

131Imetaiodobenzylguanidine therapy of malignant pheochromocytoma: interference of medication

1 reference

12 December 2020

Uptake and release of iodine-labelled m-iodobenzylguanidine in a neuroblastoma cell culture system and its importance in neuroblastoma therapy

1 reference

12 December 2020

131-I-metaiodobenzylguanidine treatment in patients with refractory advanced neuroblastoma

1 reference

12 December 2020

Scintigraphy and treatment of medullary carcinoma of the thyroid with iodine-131 metaiodobenzylguanidine

1 reference

12 December 2020

Radiopharmaceutical treatment of malignant pheochromocytoma

1 reference

12 December 2020

The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131]iodobenzylguanidine (I-131 MIBG) in man: evaluation by scintigraphy

1 reference

12 December 2020

Radiopharmacokinetics and radiation absorbed dose calculations from 131I-meta-iodobenzylguanidine (131I-MIBG).

1 reference

12 December 2020

Radiotoxicity of 125I in mammalian cells

1 reference

12 December 2020

SIMS microscopy imaging of the intratumor biodistribution of metaiodobenzylguanidine in the human SK-N-SH neuroblastoma cell line xenografted into nude mice

1 reference

12 December 2020

Alterations of iodine-131 MIBG biodistribution in an anephric patient: comparison to normal and impaired renal function

1 reference

12 December 2020

Sodium dependency of uptake of norepinephrine and m-iodobenzylguanidine into cultured human pheochromocytoma cells: evidence for uptake-one

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00173043

1 reference

22 September 2017

1 reference